Convertible Loan Extension AgreementConvertible Loan Extension Agreement • October 27th, 2022 • Orgenesis Inc. • Pharmaceutical preparations
Contract Type FiledOctober 27th, 2022 Company IndustryThis Convertible Loan Extension Agreement (“Extension”) is entered into as of October23, 2022 (the “Extension Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Yehuda Nir (“Lender”). Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”. Any term not defined herein shall have the meaning ascribed to it in the CN (as defined below).
Convertible Loan Extension AgreementConvertible Loan Extension Agreement • October 27th, 2022 • Orgenesis Inc. • Pharmaceutical preparations
Contract Type FiledOctober 27th, 2022 Company IndustryThis Convertible Loan Extension Agreement (“Extension”) is entered into as of October 23, 2022 (the “Extension Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Ricky Neumann (“Lender”). Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”. Any term not defined herein shall have the meaning ascribed to it in the CN (as defined below).
ContractConvertible Loan Extension Agreement • April 22nd, 2022
Contract Type FiledApril 22nd, 2022Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.